TXG EBITDA Margin
10X Genomics Inc Class A · EBITDA Margin
TXG EBITDA Margin
Latest reported6.11%period ending
TXG EBITDA Margin (-19.17% → 6.11%)
Annual ebitda margin
High-resolution chart · PNG
TXG ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0.6081% | |
| -21.937% | |
| -33.1505% | |
| -24.8812% | |
| -5.0144% | |
| -171.9196% | |
| -8.4948% | |
| -72.5048% | |
| -19.1672% |